Aster DM Healthcare Limited - Balance (Quarterly)

Aster DM Healthcare Limited
IN ˙ BSE ˙ INE914M01019
705,40 ₹ ↑17,60 (2,56%)
2026-04-24
DEL PRIS
Balance (Quarterly)

Aster DM Healthcare Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 3.561 3.434 2.766 3.785 4.592 822 15.767 1.646 12.742
Ændring (%) -3,57 -19,43 36,83 21,31 -82,09 1.817,48 -89,56 674,18
Aktiver Nuværende 38.396 40.965 44.331 49.216 51.954 141.653 20.978 19.015 18.765
Ændring (%) 6,69 8,22 11,02 5,56 172,65 -85,19 -9,36 -1,31
Aktiver 119.700 125.462 136.464 148.812 157.084 179.913 66.876 66.064 78.083
Ændring (%) 4,81 8,77 9,05 5,56 14,53 -62,83 -1,21 18,19
Forpligtelser 79.439 80.636 89.599 100.207 108.997 129.612 30.861 29.549 30.368
Ændring (%) 1,51 11,11 11,84 8,77 18,91 -76,19 -4,25 2,77
Egenkapital 40.261 44.826 46.865 48.605 48.086 50.301 36.015 36.514 47.715
Ændring (%) 11,34 4,55 3,71 -1,07 4,61 -28,40 1,39 30,67
Passiver og Aktiekapital 119.700 125.462 136.464 148.812 157.084 179.913 66.876 66.064 78.083
Ændring (%) 4,81 8,77 9,05 5,56 14,53 -62,83 -1,21 18,19

Source: Capital IQ

Other Listings
IN:ASTERDM 705,40 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista